Briefs

NEW YORK, Oct. 19 (GenomeWeb News) - Bioinformatics company IT.OMICS has given French-Swiss drug maker Galderma access to its LSGraph data-mining technology.

LSGraph enables researchers to mine the functional relationships between all known genes, proteins, and chemical compounds in the scientific literature.

Galderma is the fifth drug maker to license the technology in the past six months. The other four were Aventis, UCB Pharma, Proskelia, and Genfit.

Here is the rest of the story.